Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $93.5203 (-0.67%) ($92.7775 - $94.2241) on Fri. Sep. 14, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.51% (three month average) | RSI | 42 | Latest Price | $93.5203(-0.67%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.3% a day on average for past five trading days. | Weekly Trend | ABBV declines -1.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(61%) VYM(51%) IVE(49%) SPLV(49%) IWD(48%) | Factors Impacting ABBV price | ABBV will decline at least -0.755% in a week (0% probabilities). VIXM(-14%) TLT(-14%) VXX(-13%) UUP(-11%) DIA(-10%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.755% (StdDev 1.51%) | Hourly BBV | 0 () | Intraday Trend | -0.6% | | | |
|
1 - 5 Day Possible Target | $89.34(-4.47%) | Resistance Level | $93.84 | 5 Day Moving Average | $92.32(1.3%) | 10 Day Moving Average | $92.45(1.16%) | 20 Day Moving Average | $93.84(-0.34%) | To recent high | -3.2% | To recent low | 7.6% | Market Cap | $164.996b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |